Miss Poramaporn Pavarjkit

Director (Authorized Signatory), Deputy Chief Executive Officer

• Member of the Nomination and Remuneration Committee
• Executive director
• Corporate Governance Working Group
• Risk Management Working Group
• Chairman of the Working Group on Social Responsibility
• Deputy Chief Executive Officer

• Master of Business Administration (MBA), University of Wisconsin, USA.
• Bachelor of Political Science (Second-Class Honors), Thammasat University

• Director Accreditation Program (DAP), Class 127/2016, Institute of Directors (IOD)
• Director Certification Program (DCP), Class 233/2017, Institute of Directors (IOD)
• Role of the Chairman Program (RCP), Class 40/2017, Institute of Directors (IOD)
• How to Develop a Risk Management Plan (HRP), Class 25/2019, Institute of Directors (IOD)
• Risk Management Program for Corporate Leaders (RCL), Class 18/2019, Institute of Directors (IOD)
• Training Program for Scout Personnel at the Advanced Leadership Knowledge Level, Class 828
• Senior Executive Program in Commerce and Trade (TEPCoT), Class 13, Institute of Trade Studies, University of the Thai Chamber of Commerce
• Occupational Health, Safety, and Environmental Committee Progra

• Director, Siam Boromarajakumari Medical Foundation
• Director, Thai Excel Foods Co., Ltd
• Managing Director, P & S Synergy Co., Ltd.

Subsidiaries

• Director (Authorized Signatory), Accu Fast Lab Center Co., Ltd.
• Director (Authorized Signatory), Suksawad Medical Co., Ltd.
• Director (Authorized Signatory), IMH Bearing Hospital Co., Ltd.
• Director (Authorized Signatory), IMH Silom Hospital Co., Ltd.
• Director (Authorized Signatory), Mahaesak Hospital Co., Ltd

Listed Company

• None

General Companies or Organizations

• None

Term of Office

• 10 years

Shareholding percentage in the company, including shares

held by the spouse and minor children

• 49.95

Relationship between directors

• Spouse of Dr. Sittiwat Kamkatwong

Legal offenses in the past 5 years

• None

Possesses the qualifications of a director as required by law and has no prohibited characteristics as specified by the Capital Market Supervisory Board's announcement.

• Yes